Avantor, Inc. (NYSE:AVTR) Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC reduced its stake in shares of Avantor, Inc. (NYSE:AVTR) by 0.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 258,121 shares of the company’s stock after selling 2,011 shares during the period. Hsbc Holdings PLC’s holdings in Avantor were worth $5,439,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Oddo BHF Asset Management Sas purchased a new position in shares of Avantor during the third quarter worth $2,586,000. Retirement Systems of Alabama purchased a new position in shares of Avantor during the third quarter worth $21,365,000. Principal Financial Group Inc. raised its holdings in shares of Avantor by 146.5% during the third quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company’s stock worth $67,996,000 after purchasing an additional 1,562,018 shares during the last quarter. Everence Capital Management Inc. purchased a new position in shares of Avantor during the fourth quarter worth $555,000. Finally, Central Pacific Bank Trust Division raised its holdings in shares of Avantor by 44.1% during the fourth quarter. Central Pacific Bank Trust Division now owns 29,400 shares of the company’s stock worth $619,000 after purchasing an additional 9,000 shares during the last quarter. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $86,019.71. Following the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP James Bramwell sold 3,758 shares of Avantor stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $65,877.74. Following the completion of the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by company insiders.

Avantor Stock Performance

Shares of NYSE:AVTR opened at $12.49 on Tuesday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The business’s 50 day moving average price is $15.91 and its 200-day moving average price is $19.64. The firm has a market capitalization of $8.51 billion, a PE ratio of 12.01, a P/E/G ratio of 1.55 and a beta of 1.24. Avantor, Inc. has a 1 year low of $12.20 and a 1 year high of $28.00.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.23. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business’s revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.22 earnings per share. As a group, equities research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on AVTR shares. Royal Bank of Canada reduced their target price on shares of Avantor from $24.00 to $20.00 and set an “outperform” rating for the company in a report on Monday. Robert W. Baird lowered their target price on shares of Avantor from $21.00 to $17.00 and set an “outperform” rating on the stock in a research note on Monday. UBS Group reaffirmed a “neutral” rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Raymond James reissued an “outperform” rating and issued a $24.00 price objective (down from $26.00) on shares of Avantor in a report on Monday, February 10th. Finally, Cowen lowered Avantor from a “buy” rating to a “hold” rating in a report on Monday. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $19.32.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.